Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MTEM | Common Stock | Award | $411K | +175K | $2.35 | 175K | Apr 2, 2024 | By SHV MTEM SPV, LLC | F1 | |
holding | MTEM | Common Stock | 406K | Apr 2, 2024 | By Sante Health Ventures I, L.P. | F2 | |||||
holding | MTEM | Common Stock | 3.33K | Apr 2, 2024 | By SHV Management Services, L.P. | F3 | |||||
holding | MTEM | Common Stock | 57.6K | Apr 2, 2024 | By Sante Health Ventures I Annex Fund, L.P. | F4 | |||||
holding | MTEM | Common Stock | 14.8K | Apr 2, 2024 | By SHVMS, LLC | F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MTEM | Pre-Funded Warrants (Right to Buy) | Award | $944K | +402K | $2.35 | 402K | Apr 2, 2024 | Common Stock | 402K | $0.00 | By SHV MTEM SPV, LLC | F1, F6 | |
transaction | MTEM | Warrants (Right to Buy) | Award | $144K | +1.15M | $0.13* | 1.15M | Apr 2, 2024 | Common Stock | 1.15M | $2.35 | By SHV MTEM SPV, LLC | F1, F7 |
Id | Content |
---|---|
F1 | The securities are held by SHV MTEM SPV, LLC ("SHV SPV"). Sante Accel Ventures IV, LLC ("Accel IV") is the managing member of SHV SPV, Sante Health Ventures IV, L.P. ("SHV IV") is the managing member of Accel IV, SHV Management Services IV, LP ("SHV IV Services") is the general partner of SHV IV and SHV Management Services IV, LLC ("SHV IV Management") is the general partner of SHV IV Services. The Reporting Person is a managing member of SHV IV Management and may be deemed to beneficially own the securities held by SHV SPV. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
F2 | The securities are held by Sante Health Ventures I, L.P. ("SHV I"). SHV Management Services, LP ("SHV Services") is the general partner of SHV I and SHV Management Services, LLC ("SHV Management") is the general partner of SHV Services. The Reporting Person is a managing member of SHV Management and may be deemed to beneficially own the securities held by SHV I. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
F3 | The securities are held by SHV Services. SHV Management is the general partner of SHV Services. The Reporting Person is a managing member of SHV Management and may be deemed to beneficially own the securities held by SHV Services. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
F4 | The securities are held by Sante Health Ventures I Annex Fund, L.P. ("Annex Fund"). SHV Annex Services, LP ("Annex Services") is the general partner of Annex Fund and SHV Management is the general partner of Annex Services. The Reporting Person is a managing member of SHV Management and may be deemed to beneficially own the securities held by Annex Fund. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
F5 | The securities are held by SHVMS, LLC ("SHVMS"). The Reporting Person is a managing member of SHVMS and may be deemed to beneficially own the securities held by SHVMS. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
F6 | The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. |
F7 | The Warrants are exercisable at any time after the date of issuance. A holder of Warrants may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. |